Growth Metrics

Mangoceuticals (MGRX) Revenue (2023 - 2026)

Mangoceuticals recorded quarterly Revenue of $67864.0 in Q1 2026, down 28.08% quarter-over-quarter from $94360.0 in Q4 2025, and down 37.91% year-over-year from $109306.0 in Q1 2025.

Mangoceuticals' Revenue history runs 4 years deep, the most recent figure standing at $67864.0 for Q1 2026.

  • In Q1 2026, Revenue fell 37.91% year-over-year to $67864.0; the TTM figure through Mar 2026 stood at $414579.0 (down 18.88% YoY), while the FY2025 annual figure was $456021.0, down 25.96% from the prior year.
  • Revenue came in at $67864.0 for Q1 2026 at Mangoceuticals, down from $94360.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $245160.0 in Q3 2023 to a low of $67864.0 in Q1 2026.
  • A 4-year average of $143942.4 and a median of $133368.0 in 2024 frame the typical range for Revenue.
  • On a YoY basis, Revenue climbed as much as 112.56% in 2024 and fell as far as 56.93% in 2024.
  • Mangoceuticals' Revenue stood at $244374.0 in 2023, then sank by 56.93% to $105247.0 in 2024, then dropped by 10.34% to $94360.0 in 2025, then fell by 28.08% to $67864.0 in 2026.
  • According to Business Quant data, Revenue over the past three periods registered $67864.0, $94360.0, and $84246.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn 835.95 Mn
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn 3.61 Bn
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn 354.64 Mn
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn 182.31 Mn
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn 145.37 Mn
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn 313.87 Mn
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn 150.84 Mn
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn 603.85 Mn
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn 309.88 Mn
10 Mangoceuticals 7.03 Mn 6.84 Mn 29,001.00 67,864.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 67,864.00
Dec 31, 2025 94,360.00
Sep 30, 2025 84,246.00
Jun 30, 2025 168,109.00
Mar 31, 2025 109,306.00
Dec 31, 2024 105,247.00
Sep 30, 2024 133,368.00
Jun 30, 2024 163,163.00
Mar 31, 2024 214,095.00
Dec 31, 2023 244,374.00
Sep 30, 2023 245,160.00
Jun 30, 2023 141,237.00
Mar 31, 2023 100,722.00